Why Revolution Medicines Stock Plummeted by Almost 17% Today
Revolution Medicines(US:RVMD) The Motley Fool·2026-01-27 00:16It doesn't look like the company will end up in the arms of an acquirer soon, after all.Monday was generally a good day for the stock market; nevertheless, some titles landed in negative territory. One that plunged well into the red was clinical-stage biotech Revolution Medicines (RVMD 16.76%), which took a nearly 17% hit to its share price after a media report published over the weekend. Buyout bluesOn Sunday, The Wall Street Journal wrote that Merck was no longer in discussions with Revolution regarding a ...